Ewa Wesolowska

Title: Ewa Wesolowska: Innovator in Chitosan Production

Introduction

Ewa Wesolowska is a notable inventor based in Lodz, Poland. She has made significant contributions to the field of biochemistry, particularly in the production of modified microcrystalline chitosan. Her innovative methods have the potential to impact various applications in medicine and biotechnology.

Latest Patents

Ewa Wesolowska holds 1 patent for her invention titled "Methods of producing modified microcrystalline chitosan and uses therefor." This patent discloses methods for producing modified microcrystalline chitosan through enzymatic, hydrolytic, or oxidative degradation of chitosan in aqueous solution. The process involves alkalizing the chitosan solution to a pH not lower than 7.0, resulting in a highly pure precipitate that can be concentrated and dried using known methods. The invention also includes alternative methods where the chitosan solution is first alkalized before undergoing degradation to achieve desired molecular weight and polydispersity.

Career Highlights

Ewa Wesolowska is currently associated with Abbott Laboratories Corporation, a leading global healthcare company. Her work focuses on advancing the applications of chitosan in various fields, showcasing her commitment to innovation and research.

Collaborations

Throughout her career, Ewa has collaborated with esteemed colleagues such as Henryk Struszczyk and Antoni Niekraszewicz. These partnerships have contributed to her research and the successful development of her patented methods.

Conclusion

Ewa Wesolowska's contributions to the field of chitosan production exemplify her innovative spirit and dedication to scientific advancement. Her work not only enhances the understanding of chitosan but also opens new avenues for its application in various industries.